Zobrazeno 1 - 10 of 62 pro vyhledávání: '"Soulès R"'
1
Akademický článek
The Cholesterol-5,6-Epoxide Hydrolase: A Metabolic Checkpoint in Several Diseases.
Autor: de Medina P; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: 'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France.; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France.; French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France., Ayadi S; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: 'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France.; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France.; French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France., Diallo K; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: 'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France.; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France.; French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France., Buñay J; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: 'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France.; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France.; French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France., Pucheu L; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: 'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France.; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France.; French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France., Soulès R; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: 'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France.; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France.; French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France., Record M; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: 'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France.; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France.; French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France., Brillouet S; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: 'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France.; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France.; French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France.; Department of Radiopharmacy, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France., Vija L; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: 'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France.; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France.; French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France.; Department of Medical Imaging, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France., Courbon F; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: 'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France.; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France.; French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France.; Department of Medical Imaging, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France., Silvente-Poirot S; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: 'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France.; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France.; French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France., Poirot M; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: 'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France. marc.poirot@inserm.fr.; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France. marc.poirot@inserm.fr.; French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France. marc.poirot@inserm.fr.
Publikováno v: Advances in experimental medicine and biology [Adv Exp Med Biol] 2024; Vol. 1440, pp. 149-161.
Zobrazit plný text záznamu
2
Akademický článek
27-Hydroxylation of oncosterone by CYP27A1 switches its activity from pro-tumor to anti-tumor.
Autor: Ayadi S; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV:'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France; French Network for Nutrition Physical Acitivity and Cancer Research (NACRe network), Jouy en Josas, France., Friedrichs S; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany., Soulès R; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV:'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France; French Network for Nutrition Physical Acitivity and Cancer Research (NACRe network), Jouy en Josas, France., Pucheu L; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV:'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France; French Network for Nutrition Physical Acitivity and Cancer Research (NACRe network), Jouy en Josas, France., Lütjohann D; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany., Silvente-Poirot S; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV:'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France. Electronic address: sandrine.poirot@inserm.fr., Poirot M; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV:'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France; French Network for Nutrition Physical Acitivity and Cancer Research (NACRe network), Jouy en Josas, France. Electronic address: marc.poirot@inserm.fr., de Medina P; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV:'Cholesterol Metabolism and Therapeutic Innovations', Toulouse, France; Equipe labellisée par la Ligue Nationale contre le Cancer, Toulouse, France; French Network for Nutrition Physical Acitivity and Cancer Research (NACRe network), Jouy en Josas, France. Electronic address: philippe.de-medina@inserm.fr.
Publikováno v: Journal of lipid research [J Lipid Res] 2023 Dec; Vol. 64 (12), pp. 100479. Date of Electronic Publication: 2023 Nov 20.
Zobrazit plný text záznamu
3
Akademický článek
Chemical synthesis and biochemical properties of cholestane-5α,6β-diol-3-sulfonate: A non-hydrolysable analogue of cholestane-5α,6β-diol-3β-sulfate.
Autor: de Médina P; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: Cholesterol Metabolism and Therapeutic Innovations, Toulouse, France; Equipe labellisée par la Ligue Nationale contre le Cancer, France; French network for Nutrition physical Acitivity And Cancer Research (NACRe network), France. Electronic address: philippe.de-medina@inserm.fr., Ayadi S; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: Cholesterol Metabolism and Therapeutic Innovations, Toulouse, France; Equipe labellisée par la Ligue Nationale contre le Cancer, France., Soulès R; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: Cholesterol Metabolism and Therapeutic Innovations, Toulouse, France; Equipe labellisée par la Ligue Nationale contre le Cancer, France; French network for Nutrition physical Acitivity And Cancer Research (NACRe network), France., Payre B; Centre de Microscopie Electronique Appliquée à la Biologie, Faculté de Médecine Rangueil, Toulouse, France., Rup-Jacques S; Laboratory of Chemistry and Physics Multi-Scale Approach to Complex Environments, Department of Chemistry, University Lorraine, 57070 Metz, France., Silvente-Poirot S; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: Cholesterol Metabolism and Therapeutic Innovations, Toulouse, France; Equipe labellisée par la Ligue Nationale contre le Cancer, France; French network for Nutrition physical Acitivity And Cancer Research (NACRe network), France. Electronic address: sandrine.poirot@inserm.fr., Samadi M; Laboratory of Chemistry and Physics Multi-Scale Approach to Complex Environments, Department of Chemistry, University Lorraine, 57070 Metz, France. Electronic address: mohammad.samadi@univ-lorraine.fr., Poirot M; Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse, Team INOV: Cholesterol Metabolism and Therapeutic Innovations, Toulouse, France; Equipe labellisée par la Ligue Nationale contre le Cancer, France; French network for Nutrition physical Acitivity And Cancer Research (NACRe network), France. Electronic address: marc.poirot@inserm.fr.
Publikováno v: The Journal of steroid biochemistry and molecular biology [J Steroid Biochem Mol Biol] 2023 Nov; Vol. 234, pp. 106396. Date of Electronic Publication: 2023 Sep 06.
Zobrazit plný text záznamu
4
Akademický článek
Targeting the liver X receptor with dendrogenin A differentiates tumour cells to secrete immunogenic exosome-enriched vesicles.
Autor: Record M; Team 'Cholesterol Metabolism and Therapeutic Innovations' Cancer Research Centre of Toulouse (CRCT), UMR 1037 INSERM, UMR 5071 CNRS, Université de Toulouse III, Equipe labellisée par la Ligue Nationale Contre le Cancer, French network for Nutrition And Cancer Research (NACRe network), France., Attia M; Team 'Cholesterol Metabolism and Therapeutic Innovations' Cancer Research Centre of Toulouse (CRCT), UMR 1037 INSERM, UMR 5071 CNRS, Université de Toulouse III, Equipe labellisée par la Ligue Nationale Contre le Cancer, French network for Nutrition And Cancer Research (NACRe network), France., Carayon K; Team 'Cholesterol Metabolism and Therapeutic Innovations' Cancer Research Centre of Toulouse (CRCT), UMR 1037 INSERM, UMR 5071 CNRS, Université de Toulouse III, Equipe labellisée par la Ligue Nationale Contre le Cancer, French network for Nutrition And Cancer Research (NACRe network), France., Pucheu L; Team 'Cholesterol Metabolism and Therapeutic Innovations' Cancer Research Centre of Toulouse (CRCT), UMR 1037 INSERM, UMR 5071 CNRS, Université de Toulouse III, Equipe labellisée par la Ligue Nationale Contre le Cancer, French network for Nutrition And Cancer Research (NACRe network), France., Bunay J; Team 'Cholesterol Metabolism and Therapeutic Innovations' Cancer Research Centre of Toulouse (CRCT), UMR 1037 INSERM, UMR 5071 CNRS, Université de Toulouse III, Equipe labellisée par la Ligue Nationale Contre le Cancer, French network for Nutrition And Cancer Research (NACRe network), France., Soulès R; Team 'Cholesterol Metabolism and Therapeutic Innovations' Cancer Research Centre of Toulouse (CRCT), UMR 1037 INSERM, UMR 5071 CNRS, Université de Toulouse III, Equipe labellisée par la Ligue Nationale Contre le Cancer, French network for Nutrition And Cancer Research (NACRe network), France., Ayadi S; Team 'Cholesterol Metabolism and Therapeutic Innovations' Cancer Research Centre of Toulouse (CRCT), UMR 1037 INSERM, UMR 5071 CNRS, Université de Toulouse III, Equipe labellisée par la Ligue Nationale Contre le Cancer, French network for Nutrition And Cancer Research (NACRe network), France., Payré B; Team 'Cholesterol Metabolism and Therapeutic Innovations' Cancer Research Centre of Toulouse (CRCT), UMR 1037 INSERM, UMR 5071 CNRS, Université de Toulouse III, Equipe labellisée par la Ligue Nationale Contre le Cancer, French network for Nutrition And Cancer Research (NACRe network), France., Perrin-Cocon L; Team ' VIRal Infection, Metabolism and Immunity, CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France., Bourgailh F; Centre de Microscopie Electronique Appliquée à la Biologie, Faculté de Médecine Rangueil, Toulouse, France., Lamazière A; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP.SU, Hôpital Saint Antoine, Département de métabobolomique clinique, Paris, France., Lotteau V; Team ' VIRal Infection, Metabolism and Immunity, CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France., Poirot M; Team 'Cholesterol Metabolism and Therapeutic Innovations' Cancer Research Centre of Toulouse (CRCT), UMR 1037 INSERM, UMR 5071 CNRS, Université de Toulouse III, Equipe labellisée par la Ligue Nationale Contre le Cancer, French network for Nutrition And Cancer Research (NACRe network), France., Silvente-Poirot S; Team 'Cholesterol Metabolism and Therapeutic Innovations' Cancer Research Centre of Toulouse (CRCT), UMR 1037 INSERM, UMR 5071 CNRS, Université de Toulouse III, Equipe labellisée par la Ligue Nationale Contre le Cancer, French network for Nutrition And Cancer Research (NACRe network), France., de Medina P; Team 'Cholesterol Metabolism and Therapeutic Innovations' Cancer Research Centre of Toulouse (CRCT), UMR 1037 INSERM, UMR 5071 CNRS, Université de Toulouse III, Equipe labellisée par la Ligue Nationale Contre le Cancer, French network for Nutrition And Cancer Research (NACRe network), France.
Publikováno v: Journal of extracellular vesicles [J Extracell Vesicles] 2022 Apr; Vol. 11 (4), pp. e12211.
Zobrazit plný text záznamu
5
Akademický článek
The 5,6-epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets.
Autor: de Medina P; UMR-1037, Cancer Research Center of Toulouse (CRCT), Team 'Cholesterol Metabolism and Therapeutic Innovations'; Equipe labellisée par la Ligue Nationale Contre le Cancer, The French Network for Nutrition and Cancer Research (NACRe Network), INSERM-Université de Toulouse, Toulouse, France., Diallo K; UMR-1037, Cancer Research Center of Toulouse (CRCT), Team 'Cholesterol Metabolism and Therapeutic Innovations'; Equipe labellisée par la Ligue Nationale Contre le Cancer, The French Network for Nutrition and Cancer Research (NACRe Network), INSERM-Université de Toulouse, Toulouse, France., Huc-Claustre E; UMR-1037, Cancer Research Center of Toulouse (CRCT), Team 'Cholesterol Metabolism and Therapeutic Innovations'; Equipe labellisée par la Ligue Nationale Contre le Cancer, The French Network for Nutrition and Cancer Research (NACRe Network), INSERM-Université de Toulouse, Toulouse, France., Attia M; UMR-1037, Cancer Research Center of Toulouse (CRCT), Team 'Cholesterol Metabolism and Therapeutic Innovations'; Equipe labellisée par la Ligue Nationale Contre le Cancer, The French Network for Nutrition and Cancer Research (NACRe Network), INSERM-Université de Toulouse, Toulouse, France., Soulès R; UMR-1037, Cancer Research Center of Toulouse (CRCT), Team 'Cholesterol Metabolism and Therapeutic Innovations'; Equipe labellisée par la Ligue Nationale Contre le Cancer, The French Network for Nutrition and Cancer Research (NACRe Network), INSERM-Université de Toulouse, Toulouse, France., Silvente-Poirot S; UMR-1037, Cancer Research Center of Toulouse (CRCT), Team 'Cholesterol Metabolism and Therapeutic Innovations'; Equipe labellisée par la Ligue Nationale Contre le Cancer, The French Network for Nutrition and Cancer Research (NACRe Network), INSERM-Université de Toulouse, Toulouse, France., Poirot M; UMR-1037, Cancer Research Center of Toulouse (CRCT), Team 'Cholesterol Metabolism and Therapeutic Innovations'; Equipe labellisée par la Ligue Nationale Contre le Cancer, The French Network for Nutrition and Cancer Research (NACRe Network), INSERM-Université de Toulouse, Toulouse, France.
Publikováno v: British journal of pharmacology [Br J Pharmacol] 2021 Aug; Vol. 178 (16), pp. 3248-3260. Date of Electronic Publication: 2020 Aug 23.
Zobrazit plný text záznamu
6
Akademický článek
A fast UPLC-HILIC method for an accurate quantification of dendrogenin A in human tissues.
Autor: Soulès R; Team « Cholesterol metabolism and therapeutic innovations », Cancer Research Center of Toulouse, UMR 1037 INSERM-University of Toulouse, Toulouse, France; Equipe labellisée par la Ligue Nationale Contre le Cancer, France., Audouard-Combe F; Waters S.A.S., Saint-Quentin En Yvelines, France., Huc-Claustre E; Team « Cholesterol metabolism and therapeutic innovations », Cancer Research Center of Toulouse, UMR 1037 INSERM-University of Toulouse, Toulouse, France; Equipe labellisée par la Ligue Nationale Contre le Cancer, France., de Medina P; Team « Cholesterol metabolism and therapeutic innovations », Cancer Research Center of Toulouse, UMR 1037 INSERM-University of Toulouse, Toulouse, France; Equipe labellisée par la Ligue Nationale Contre le Cancer, France., Rives A; Affichem, Toulouse, France; Dendrogenix, Liège, Belgium., Chatelut E; Team 'Dose individualization of anticancer drugs », Cancer Research Center of Toulouse, UMR 1037 INSERM-University of Toulouse, Toulouse, France; Institut Claudius Regaud, Institut Universitaire du Cancer-Oncopole, Toulouse, France., Dalenc F; Team « Cholesterol metabolism and therapeutic innovations », Cancer Research Center of Toulouse, UMR 1037 INSERM-University of Toulouse, Toulouse, France; Equipe labellisée par la Ligue Nationale Contre le Cancer, France; Institut Claudius Regaud, Institut Universitaire du Cancer-Oncopole, Toulouse, France., Franchet C; Service d'Anatomo-Pathologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Silvente-Poirot S; Team « Cholesterol metabolism and therapeutic innovations », Cancer Research Center of Toulouse, UMR 1037 INSERM-University of Toulouse, Toulouse, France; Equipe labellisée par la Ligue Nationale Contre le Cancer, France., Poirot M; Team « Cholesterol metabolism and therapeutic innovations », Cancer Research Center of Toulouse, UMR 1037 INSERM-University of Toulouse, Toulouse, France; Equipe labellisée par la Ligue Nationale Contre le Cancer, France. Electronic address: marc.poirot@inserm.fr., Allal B; Team 'Dose individualization of anticancer drugs », Cancer Research Center of Toulouse, UMR 1037 INSERM-University of Toulouse, Toulouse, France; Institut Claudius Regaud, Institut Universitaire du Cancer-Oncopole, Toulouse, France. Electronic address: allal.ben@iuct-oncopole.fr.
Publikováno v: The Journal of steroid biochemistry and molecular biology [J Steroid Biochem Mol Biol] 2019 Nov; Vol. 194, pp. 105447. Date of Electronic Publication: 2019 Aug 12.
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje